Douglas Evan Godshall - 18 Nov 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
/s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Issuer symbol
N/A
Transactions as of
18 Nov 2021
Net transactions value
-$9,173,940
Form type
4
Filing time
22 Nov 2021, 20:00:41 UTC
Previous filing
20 Aug 2021
Next filing
15 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $153,720 +45,000 +33% $3.42 181,856 18 Nov 2021 Direct F1
transaction SWAV Common Stock Sale $347,735 -1,700 -0.93% $204.55 180,156 18 Nov 2021 Direct F2
transaction SWAV Common Stock Sale $814,200 -3,958 -2.2% $205.71 176,198 18 Nov 2021 Direct F3
transaction SWAV Common Stock Sale $3,063,110 -14,827 -8.4% $206.59 161,371 18 Nov 2021 Direct F4
transaction SWAV Common Stock Sale $2,841,591 -13,703 -8.5% $207.37 147,668 18 Nov 2021 Direct F5
transaction SWAV Common Stock Sale $1,299,684 -6,232 -4.2% $208.55 141,436 18 Nov 2021 Direct F6
transaction SWAV Common Stock Sale $792,288 -3,780 -2.7% $209.60 137,656 18 Nov 2021 Direct F7
transaction SWAV Common Stock Sale $63,042 -300 -0.22% $210.14 137,356 18 Nov 2021 Direct F8
transaction SWAV Common Stock Sale $106,010 -500 -0.36% $212.02 136,856 18 Nov 2021 Direct F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -45,000 -8.5% $0.000000 484,799 18 Nov 2021 Common Stock 45,000 $3.42 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 12/09/2020.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.01 to $204.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.01 to $206.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $206.01 to $207.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.01 to $207.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $208.06 to $209.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $209.07 to $210.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.09 to $210.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F9 The reported securities were sold at a price of $212.02.
F10 Twenty-Five percent of the shares subject to this option vested on 05/09/2018 and the balance of the shares vested in equal monthly installments thereafter for 36 months.